Exclusive: Son of pro-crypto New York Senator Kirsten Gillibrand raises $30 million to launch a derivatives exchange

Theodore Gillibrand’s startup, American Perpetuals Exchange Corporation, raised $30 million at a $300 million valuation in a Lux Capital-led round. The company plans to seek CFTC approval to list perpetual futures on equities and stock indices, expanding the perps model beyond crypto into a regulated U.S. market. The news is constructive for fintech and derivatives innovation, though the direct market impact is likely limited.

Analysis

The strategic implication is not the startup itself, but the legitimization of listed perpetuals as a product category inside U.S. market structure. If even a small share of offshore crypto perps and retail-index speculation migrates onshore, the margin pool shifts from unregulated venues to regulated intermediaries: clearing, market-making, prime brokerage, and exchange-tech vendors stand to capture recurring revenue with far lower regulatory risk. The second-order effect is competitive pressure on traditional listed options venues, because perps are simpler to hold, cheaper to roll, and can become the preferred vehicle for short-horizon directional exposure if approvals broaden beyond a single contract set.

The biggest near-term catalyst is regulatory precedent, not user adoption. A CFTC green light for equity and index perps would be an important signal that U.S. regulators are willing to tolerate always-on leverage in a wrapper that looks less like gambling and more like exchange-traded hedging. That would likely pull in a wave of venture-backed entrants and force incumbents to respond with product innovation, fee compression, and more 24/7 risk management infrastructure. The timeline matters: this is a months-to-years theme, but the market can re-rate quickly on any filing, comment period, or first contract approval.

The contrarian view is that the market is likely overestimating how fast institutional adoption can scale. Perps are attractive in crypto because they exploit continuous trading and fragmented liquidity; U.S. equities are already deeply served by options, futures, and ETFs, so perps may cannibalize mostly speculative flow rather than durable hedging demand. The main tail risk is a regulatory backlash if a few high-profile losses or manipulation events occur, which could freeze approvals and compress valuation multiples across adjacent fintech and prediction-market names within days.

The cleanest trade is to own the picks-and-shovels rather than the startup outcome: a basket long exchange/clearing infrastructure and short pure-play retail-speculation names if listed perp adoption proves real. Near term, the best asymmetry is in call spreads on infrastructure beneficiaries into any CFTC headline cycle, because optionality is cheap relative to the probability of a multi-year product expansion. If approvals stall, the trade should revert quickly; if they accelerate, the monetization path compounds through volume, not just one company.

Key Decisions for Investors

• Long CME / ICE vs short a basket of high-multiple retail trading/fintech names over 3-6 months; thesis is that regulated perp adoption accrues to incumbents with clearing, market data, and distribution advantages while speculative app-only models face fee compression.
• Buy 6-12 month call spreads on CBOE or CME into any CFTC approval headlines; use spreads rather than outright calls because the market may underprice a multi-year product expansion but overprice near-term monetization.
• Monitor Kalshi as a sentiment barometer; if further perp product approvals follow, add to a long-vs-short pair in market-structure beneficiaries versus options-heavy retail brokers, with a 2:1 to 3:1 reward/risk on regulatory follow-through.
• Avoid chasing the startup valuation directly; the risk/reward is poor until there is evidence of licensure and liquidity formation. Treat it as a signal trade, not a fundamental long.
• If the CFTC process stalls or commentary turns hostile, fade the theme by shorting high-beta fintech/crypto-adjacent names for 1-3 months; the entire valuation stack depends on regulatory permission, not consumer demand.